Infectious Disease Market | Discover Top Trends and Drivers
Market Growth and Forecasts for 2021-2025

Infectious disease market is set to post an incremental growth of $ 62.83 bn during 2021-2025. The market will decelerate at a CAGR of  10.19% during the forecast period. Our analysts provide a detailed understanding of the market focusing on the latest trends, and drivers that are likely to impact growth. This analysis will enable business leaders to strategize and plan for further growth of their business.


Rely on our business insights to implement a COVID-19 Recovery Plan: Request for Free Sample Report


Infectious Disease Market: Market Segments and Key Trends

This report provides a detailed analysis of the market by Product (drugs and vaccines) and Geography (North America, Europe, Asia, and ROW). 40% of the market growth will originate from North America during the forecast period. This research report provides a detailed analysis of all the segments, key trends, and challenges that are likely to influence growth.

Infectious Disease Market: What are the Growth Drivers?

The Increasing prevalence of infectious diseases is one of the primary factors driving the growth of the infectious disease market. The report provides a detailed study of all the factors that are likely to boost the market. An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals.

Infectious Disease Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Vendor Analysis: AbbVie Inc., Boehringer Ingelheim International GmbH and F. Hoffmann-La Roche Ltd. are key growth contributors

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Infectious Disease Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive infectious disease market growth during the next five years
  • Precise estimation of the infectious disease market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the infectious disease market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of infectious disease market vendors

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is decelerate at a CAGR of 10.19%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 62.83 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Increasing prevalence of infectious diseases will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    40% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are AbbVie Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.

     
  7. What are the market segments covered in this report?
    The market is segmented by Product (drugs and vaccines) and Geography (North America, Europe, Asia, and ROW)
Read More Read Less
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>